Michael F. Oliver

1.8k total citations
37 papers, 1.3k citations indexed

About

Michael F. Oliver is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael F. Oliver has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael F. Oliver's work include Cardiac Imaging and Diagnostics (8 papers), Lipoproteins and Cardiovascular Health (8 papers) and Cardiovascular Function and Risk Factors (7 papers). Michael F. Oliver is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Lipoproteins and Cardiovascular Health (8 papers) and Cardiovascular Function and Risk Factors (7 papers). Michael F. Oliver collaborates with scholars based in United Kingdom, United States and Norway. Michael F. Oliver's co-authors include Desmond G. Julian, Peter Ganz, David D. Waters, Anders Olsson, Gregory G. Schwartz, Rudolph A. Riemersma, Andreas M. Zeiher, Michael D. Ezekowitz, Ingar Holme and H. A. Dewar and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Michael F. Oliver

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael F. Oliver United Kingdom 20 656 544 258 141 120 37 1.3k
K L Woods United Kingdom 18 957 1.5× 228 0.4× 333 1.3× 88 0.6× 245 2.0× 54 2.0k
Alessandro Pierucci Italy 22 393 0.6× 229 0.4× 185 0.7× 62 0.4× 160 1.3× 65 1.7k
X. H. Krauss Netherlands 20 1.8k 2.8× 808 1.5× 376 1.5× 145 1.0× 146 1.2× 39 2.4k
James M. McLenachan United Kingdom 16 2.1k 3.2× 562 1.0× 282 1.1× 73 0.5× 213 1.8× 48 2.8k
Matthew J. Sorrentino United States 17 444 0.7× 287 0.5× 126 0.5× 41 0.3× 145 1.2× 43 1.1k
Milada Dobiášová Czechia 10 434 0.7× 434 0.8× 760 2.9× 23 0.2× 155 1.3× 15 1.6k
Søren Rasmussen Denmark 13 1.0k 1.5× 323 0.6× 299 1.2× 31 0.2× 121 1.0× 27 1.9k
R D Abbott United States 11 588 0.9× 753 1.4× 995 3.9× 35 0.2× 185 1.5× 12 2.2k
Joseph R. Benotti United States 16 731 1.1× 193 0.4× 277 1.1× 73 0.5× 167 1.4× 37 1.4k
Antone F. Salel United States 18 648 1.0× 324 0.6× 124 0.5× 43 0.3× 80 0.7× 54 1.1k

Countries citing papers authored by Michael F. Oliver

Since Specialization
Citations

This map shows the geographic impact of Michael F. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Oliver more than expected).

Fields of papers citing papers by Michael F. Oliver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Oliver. The network helps show where Michael F. Oliver may publish in the future.

Co-authorship network of co-authors of Michael F. Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Oliver. A scholar is included among the top collaborators of Michael F. Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Oliver. Michael F. Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliver, Michael F.. (2012). The clofibrate saga: a retrospective commentary. British Journal of Clinical Pharmacology. 74(6). 907–910. 19 indexed citations
2.
Oliver, Michael F.. (2002). Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. The American Journal of Medicine. 112(4). 305–311. 65 indexed citations
3.
4.
Wright, Robert A., et al.. (1993). Exercise tolerance in angina is improved by mivazerol?An alpha2-adrenoceptor agonist. Cardiovascular Drugs and Therapy. 7(6). 929–934. 18 indexed citations
5.
Sidhu, Mandeep S., David Crook, Ian F. Godsland, et al.. (1992). Inverse Relationship Between Serum Lp(a) Levels and First-Phase Insulin Secretion. Diabetes. 41(10). 1341–1345. 23 indexed citations
6.
Oliver, Michael F.. (1992). Cholesterol and coronary disease ?Outstanding questions. Cardiovascular Drugs and Therapy. 6(2). 131–136. 11 indexed citations
7.
Riemersma, R. A., et al.. (1990). Effects of safflower oil and evening primrose oil in men with a low dihomo-γ-linolenic level. Atherosclerosis. 81(3). 199–208. 10 indexed citations
8.
Riemersma, Rudolph A., et al.. (1989). Adipose fatty acid composition and the risk of serious ventricular arrhythmias in acute myocardial infarction. The American Journal of Cardiology. 63(5). 269–272. 32 indexed citations
9.
Oliver, Michael F., et al.. (1989). Blood Pressure, Cigarette Smoking and Heart Attack in the WHO Co-operative Trial of Clofibrate. International Journal of Epidemiology. 18(2). 355–360. 14 indexed citations
10.
Riemersma, R. A., et al.. (1989). Low Plasma Vitamins E and C Increased Risk of Angina in Scottish Mena. Annals of the New York Academy of Sciences. 570(1). 291–295. 53 indexed citations
11.
Oliver, Michael F.. (1988). Reducing cholesterol does not reduce mortality. Journal of the American College of Cardiology. 12(3). 814–815. 52 indexed citations
12.
Elton, Robert A., et al.. (1988). Individual variation in the dietary intake of a group of Scottish men. Journal of Human Nutrition and Dietetics. 1(1). 47–57. 7 indexed citations
13.
Brandenburg, Robert O., Valentı́n Fuster, Bernard J. Gersh, et al.. (1985). Clinical problems relevant to sudden death: Discussion. Journal of the American College of Cardiology. 5(6). 190B–191B. 1 indexed citations
14.
Oliver, Michael F.. (1985). Lessons from epidemiology: Summary of general discussion. Journal of the American College of Cardiology. 5(6). 155B–156B. 4 indexed citations
15.
Oliver, Michael F.. (1985). Lack of impact of prevention on sudden cardiac death. Journal of the American College of Cardiology. 5(6). 150B–154B. 7 indexed citations
16.
Russell, Douglas C., et al.. (1984). Mechanisms of phase 1a and 1b early ventricular arrhythmias during acute myocardial ischemia in the dog. The American Journal of Cardiology. 53(2). 307–312. 30 indexed citations
17.
Strange, Richard C., Norman Vetter, Michael Rowe, & Michael F. Oliver. (1974). Plasma Cyclic AMP and Total Catecholamines during Acute Myocardial Infarction in Man. European Journal of Clinical Investigation. 4(1). 115–119. 34 indexed citations
18.
Strange, Richard C., Norman Vetter, Michael Rowe, & Michael F. Oliver. (1974). Plasma Cyclic AMP and Total Catecholamines during Acute Myocardial Infarction in Man. European Journal of Clinical Investigation. 4(2). 115–119. 32 indexed citations
19.
Oliver, Michael F.. (1968). The Place of the Coronary Care Unit. Journal of the Royal College of Physicians of London. 3(1). 47–54. 7 indexed citations
20.
Oliver, Michael F., Desmond G. Julian, & K. W. Donald. (1967). Problems in evaluating coronary care units. The American Journal of Cardiology. 20(4). 465–474. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K L Woods Breakdown of academic impact, for papers by Alessandro Pierucci Breakdown of academic impact, for papers by X. H. Krauss Breakdown of academic impact, for papers by James M. McLenachan Breakdown of academic impact, for papers by Matthew J. Sorrentino Breakdown of academic impact, for papers by Milada Dobiášová Breakdown of academic impact, for papers by Søren Rasmussen Breakdown of academic impact, for papers by R D Abbott Breakdown of academic impact, for papers by Joseph R. Benotti Breakdown of academic impact, for papers by Antone F. Salel
Rankless by CCL
2026